The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Galan Lithium
GLN:AU
International Graphite
IG6:AU
Cardiex Limited
CDX:AU
CVD Equipment Corporation
CVV:US
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
CorMedix Will Be Part of Panel at Biotech Conference
Sep. 12, 2017 09:04AM PST
Pharmaceutical InvestingCorMedix announced its chief scientific officer Dr. Antony Pfaffle will present at an upcoming biotech conference.
CorMedix (NYSE:CRMD) announced its chief scientific officer Dr. Antony Pfaffle will present at an upcoming biotech conference.
As quoted in the press release:
Dr. Pfaffle will participate on a panel titled, ”Regulatory Challenges: Expanding Endpoints,” along with Arsanis’ Chief Development Officer, David Mantus, and moderated by Chief Executive Officer of Scynexis, Marco Taglietti. The panel is scheduled for 11:30 a.m. – 12:00 p.m. ET on Tuesday, September 19, 2017.
Click here to read the full press release.
Source: www.accesswire.com
Outlook Reports
Featured Pharmaceutical Investing Stocks
Browse Companies
MARKETS
COMMODITIES
| Commodities | |||
|---|---|---|---|
| Gold | 2324.59 | +8.29 | |
| Silver | 27.36 | +0.18 | |
| Copper | 4.55 | +0.07 | |
| Oil | 82.84 | +0.03 | |
| Heating Oil | 2.57 | +0.01 | |
| Natural Gas | 1.65 | -0.01 | |
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.